Marimed (MRMD) Non-Current Deferred Tax Liability (2017 - 2019)
Marimed (MRMD) posted quarterly Non-Current Deferred Tax Liability of $5.4 million for Q4 2019, up 53.62% year-over-year from $3.5 million in Q4 2018, and up 53.62% quarter-over-quarter from $3.5 million in Q4 2018.
Marimed (MRMD) Non-Current Deferred Tax Liability (2017 - 2019) Analysis & Trends
Marimed (MRMD) has reported Non-Current Deferred Tax Liability for 3 consecutive years, with $5.4 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Non-Current Deferred Tax Liability rose 53.62% year-over-year to $5.4 million; the TTM figure through Dec 2019 stood at $5.4 million (up 53.62% YoY), while the FY2019 annual figure was $5.4 million, up 53.62% from the prior year.
- Non-Current Deferred Tax Liability improved to $5.4 million in Q4 2019 per MRMD's latest filing, from $3.5 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $5.4 million in Q4 2019 and bottomed at $10918.0 in Q4 2017.
- Historically, Non-Current Deferred Tax Liability has averaged $3.0 million across 3 years, with a median of $3.5 million in 2018.
- Annual changes were most pronounced in 2018 — Non-Current Deferred Tax Liability surged 32224.3% — and 2019, when it jumped 53.62%.
- Marimed's Non-Current Deferred Tax Liability stood at $10918.0 in 2017, then soared by 32224.3% to $3.5 million in 2018, then jumped by 53.62% to $5.4 million in 2019.
- Business Quant data shows MRMD's Non-Current Deferred Tax Liability at $5.4 million in Q4 2019, $3.5 million in Q4 2018, and $10918.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 5.42 Mn |
| Dec 31, 2019 | 5.42 Mn |
| Dec 31, 2018 | 3.53 Mn |
| Dec 31, 2018 | 3.53 Mn |
| Dec 31, 2017 | 10,918.00 |
| Dec 31, 2017 | 10,918.00 |